This is potentially about more than weight gain. The DNA-PK-mediated pathway they've discovered looks an awful lot like something you'd design to control senesc

This is potentially about more than weight gain. The DNA-PK-mediated pathway they've discovered looks an awful lot like something you'd design to control senescence. The DNA-PK inhibitor used, NU7441, is orally active and the press release even calls it drug-like. The human-equivalent dose based on bodyweight is about 3g/day (three pills worth). The actual HED is probably smaller. Currently very expensive.[1] 1 http://www.selleckchem.com/products/nu7441.html http://www.selleckchem.com/products/nu7441.html